• MDxHealth Signs Research Collaboration with University of Oxford

    Wednesday September 27th 2023

  • Agreement regarding recapitalization of operating subsidiaries by secured creditors and wind down of listed holding company

    Tuesday September 26th 2023

  • VIB and AB Biotek join forces to develop superior yeast strains for bioethanol production

    Tuesday September 26th 2023

  • SimAbs secures €1 million investment for advanced antibody production

    Monday September 25th 2023

  • argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis

    Thursday September 21st 2023

  • Galapagos appoints Simon Sturge to its Board of Directors

    Tuesday September 19th 2023

  • 13th Investment for HERAN Partners: Broken String Biosciences (UK)

    Tuesday September 19th 2023

  • The QbD Group launches its new Business & Communications division

    Monday September 18th 2023

  • Your news here?

  • AbolerIS Pharma announces €27 million in Series A financing to advance its novel treatment paradigm for autoimmune and inflammatory diseases

    Sunday September 17th 2023

  • argenx announces positive CHMP opinion for subcutaneous efgartigimod for generalized myasthenia gravis

    Friday September 15th 2023

  • New study discovers how neurons die in Alzheimer’s disease

    Friday September 15th 2023


Strategic Partners